Biweekly FOLFIRI in Advanced Gastric Cancer (AGC) With Failure of Prior Taxane, Fluoropyrimidine, and Cisplatin

Mise à jour : Il y a 4 ans
Référence : NCT00976768

Femme et Homme

Extrait

The purpose of this study is: - To observe the feasibility of biweekly oxaliplatin and infusional 5-fluorouracil (FU)/Leucovorin (LV) in patients with advanced gastric adenocarcinoma who have prior exposure to taxane, fluoropyrimidine, and cisplatin - To determine the activity of this combination regimen. - To evaluate the treatment-related toxicities.


Critère d'inclusion

  • advanced gastric cancer

Liens